论文部分内容阅读
休克型大叶肺炎为内科常见急症。病死率为6.2％至28.6％。过去在治疗休克型大叶肺炎时,多选用去甲基肾上腺素等缩血管药物,并强调限制静脉补液量。近年来对休克的病理生理有了进一步认识,认为休克时的基本病理生理变化是小血管痉挛,微循环障碍,组织血液灌注不良。因此血管扩张药,特别是异丙基肾上腺素的应用已受到重视。我院内科自1972年以来,对30例休克型大叶肺炎患者,采用异丙肾上腺素治疗,效果满意。现报告如下。
Shock lobar pneumonia is a common medical emergency. The case fatality rate was 6.2% to 28.6%. In the past in the treatment of shock lobular pneumonia, the more use of vasopressors such as norepinephrine drugs, and stressed the limits of intravenous fluid volume. In recent years, the pathophysiology of shock has been further recognized that the basic pathophysiological changes in shock is small vasospasm, microcirculation, tissue hypoperfusion. Therefore, the application of vasodilators, especially isoproterenol, has received great attention. Department of Internal Medicine Since 1972, 30 patients with shock-type lobar pneumonia, the use of isoproterenol treatment, the effect is satisfactory. The report is as follows.